At the time of writing, Astrana Health Inc [ASTH] stock is trading at $23.47, up 4.50%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ASTH shares have gain 6.34% over the last week, with a monthly amount drifted -0.38%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrana Health Inc [NASDAQ: ASTH] stock has seen the most recent analyst activity on December 12, 2025, when Needham initiated its Buy rating and assigned the stock a price target of $28. Previously, Barclays started tracking the stock with Equal Weight rating on April 01, 2025, and set its price target to $36. On October 14, 2024, TD Cowen initiated with a Buy rating and assigned a price target of $66 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Sector Weight rating. Truist upgraded its rating to a Buy and raised its price target to $50 on July 11, 2024. Robert W. Baird started tracking with an Outperform rating for this stock on May 30, 2024, and assigned it a price target of $54. In a note dated February 26, 2024, Jefferies initiated a Buy rating and provided a target price of $50 on this stock.
For the past year, the stock price of Astrana Health Inc fluctuated between $20.12 and $39.97. Currently, Wall Street analysts expect the stock to reach $30.33 within the next 12 months. Astrana Health Inc [NASDAQ: ASTH] shares were valued at $23.47 at the most recent close of the market. An investor can expect a potential return of 29.23% based on the average ASTH price forecast.
Analyzing the ASTH fundamentals
According to Astrana Health Inc [NASDAQ:ASTH], the company’s sales were 2.90B for trailing twelve months, which represents an 99.71% jump. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.4.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.74 points at the first support level, and at 22.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.10, and for the 2nd resistance point, it is at 24.72.
Ratios To Look Out For
It is important to note that Astrana Health Inc [NASDAQ:ASTH] has a current ratio of 1.40. As well, the Quick Ratio is 1.40, while the Cash Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 0.41, the price to book ratio is 1.49 and price to earnings (TTM) ratio is 123.53.
